Everpure director proposes $7.2M share sale

Two earlier 70,000-share sales are listed with gross proceeds, and the notice gives a September 26, 2025 plan adoption date.

Available on EDGAR 11/10/2026 - 04:26 PM EST Accepted by SEC EDGAR 11/10/2026 - 04:26 PM EST Learn about SEC filing dates

Rhea-AI Filing Summary

Everpure, Inc. (P) director and officer Charles Giancarlo gave notice of a proposed sale of 70,000 common shares, with an approximate sale date of November 10, 2026 and an aggregate market value of $7,198,800.00. The shares were acquired upon vesting of restricted stock units during the period from June 20 through December 20, 2019.

The notice also lists prior sales of 70,000 shares on October 12, 2026, for gross proceeds of $10,761,352.00, and 70,000 shares on September 10, 2026, for $6,657,819.00. Both are identified as Rule 10b5-1 sales; the stated plan adoption date is September 26, 2025.

Key Figures

Shares to be sold: 70,000 shares Aggregate market value: $7,198,800.00 Shares outstanding: 333,227,251 shares +4 more

7 metrics

Shares to be sold 70,000 shares Common shares; approximate sale date November 10, 2026

Aggregate market value $7,198,800.00 Proposed sale

Shares outstanding 333,227,251 shares Common shares

Prior sale shares 70,000 shares Sale dated October 12, 2026

Gross proceeds $10,761,352.00 Sale dated October 12, 2026

Prior sale shares 70,000 shares Sale dated September 10, 2026

Gross proceeds $6,657,819.00 Sale dated September 10, 2026

Key Terms

Restricted Stock Units, 10b5-1 Sales, Aggregate Market Value, Gross Proceeds

4 terms

Restricted Stock Units financial

"Nature of Acquisition Transaction | Restricted Stock Units"

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

10b5-1 Sales financial

"10b5-1 Sales for CHARLES GIANCARLO"

10b5-1 sales are pre-arranged stock-trading plans that let company insiders automatically buy or sell shares according to a fixed schedule or formula, even if they later learn confidential information. Think of it as setting up an automatic thermostat for trades: it creates a clear, documented path that can protect insiders from insider-trading accusations and gives investors a signal about predictable insider activity—though it can also simply be a way for insiders to diversify or raise cash.

Aggregate Market Value financial

"Aggregate Market Value"

Aggregate market value is the combined price you would pay to buy all outstanding shares of a company or all companies in a group at current market prices — essentially the sum of each stock’s market capitalization. It matters to investors because it shows the overall size and weight of an investment or sector (like the total cost to buy every piece of a puzzle), helps compare scale across companies or markets, and influences index composition and risk exposure.

Gross Proceeds financial

"Gross Proceeds"

The total amount of cash a company receives from a financing event or sale before any fees, expenses, taxes or deductions are taken out. Investors watch gross proceeds because it shows the raw scale of new capital being raised—think of it as the paycheck amount before withholdings—which helps assess how much funding is available for operations, growth, debt payoff or how much shareholder dilution might occur once costs are removed.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many P shares did Charles Giancarlo propose to sell?

Charles Giancarlo’s notice lists a proposed sale of 70,000 common shares, with an approximate sale date of November 10, 2026 and an aggregate market value of $7,198,800.00.

What prior P share sales does Charles Giancarlo’s notice list?

The notice lists a sale of 70,000 shares on October 12, 2026, for gross proceeds of $10,761,352.00, and a sale of 70,000 shares on September 10, 2026, for $6,657,819.00. Both are identified as Rule 10b5-1 sales, and the stated plan adoption date is September 26, 2025.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001299634
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	Everpure, Inc.
SEC File Number	001-37570
Address of Issuer	2555 Augustine Dr. Santa Clara CALIFORNIA 95054
Phone	8003797873
Name of Person for Whose Account the Securities are To Be Sold	CHARLES GIANCARLO
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Director
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	70000	7198800.00	333227251	11/10/2026	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	06/20/2019	Restricted Stock Units	Issuer			70000	06/20/2019	N/A

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
10b5-1 Sales for CHARLES GIANCARLO 2555 Augustine Dr. Santa Clara CA 95054	Common	10/12/2026	70000	10761352.00
10b5-1 Sales for CHARLES GIANCARLO 2555 Augustine Dr. Santa Clara CA 95054	Common	09/10/2026	70000	6657819.00

144: Remarks and Signature

Remarks	The securities to be sold were acquired upon the vesting of restricted stock units during the period of 06/20/2019 through 12/20/2019.
Date of Notice	11/10/2026
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	09/26/2025
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Charles Giancarlo
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)